Jimsphere wind and turbulence exceedance statistic

Exceedance statistics of winds and gusts observed over Cape Kennedy with Jimsphere balloon sensors are described. Gust profiles containing positive and negative departures, from smoothed profiles, in the wavelength ranges 100-2500, 100-1900, 100-860, and 100-460 meters were computed from 1578 profiles with four 41 weight digital high pass filters. Extreme values of the square root of gust speed are normally distributed. Monthly and annual exceedance probability distributions of normalized rms gust speeds in three altitude bands (2-7, 6-11, and 9-14 km) are log-normal. The rms gust speeds are largest in the 100-2500 wavelength band between 9 and 14 km in late winter and early spring. A study of monthly and annual exceedance probabilities and the number of occurrences per kilometer of level crossings with positive slope indicates significant variability with season, altitude, and filter configuration. A decile sampling scheme is tested and an optimum approach is suggested for drawing a relatively small random sample that represents the characteristic extreme wind speeds and shears of a large parent population of Jimsphere wind profiles

The combustion characteristics and stable carbon isotopic compositions of irradiated organic matter: implications for terrestrial and extraterrestrial sample analysis

Exposure to ionizing radiation causes the mean combustion temperature of naturally occurring, solid, terrestrial organic matter, derived from the radiation-induced polymerization of methane, to increase

A study of jimsphere wind profiles as related to space vehicle design and operations

Winds aloft and wind shear analysis from jimsphere wind sensor balloon-radar dat

A further study of Jimsphere wind profiles as related to space vehicle design and operations

Statistical characteristics of wind profiles from Jimsphere balloon sensors for space vehicle desig

Transcription antitermination: the Λ paradigm updated

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/75002/1/j.1365-2958.1995.mmi_18020191.x.pd

Analysis of Administrative Agency Adjudicatory Hearing Use of Remote Appearances and Virtual Hearings

With the advent of the COVID-19 pandemic, federal and state courts and federal adjudicatory agencies suspended most trials and hearings. Faced with the requirement to fulfill their basic mission, many resumed partial operations using computer-based video conferencing,especially for preliminary legal and procedural matters. As time passed, the use of that videoconferencing extended to bench trials in courts and to adjudicatory hearings and proceedings such as settlement meetings, mediations, arbitrations, and status conferences in federal agencies. As of this writing, there have also been a small number of remote or virtual jury trials in state and federal courts. The Administrative Conference of the United States (ACUS) initiated a project to study how federal adjudicatory agencies are using remote appearances and virtual hearings with the intent to propose recommendations for the future. The Center for Legal & Court Technology (CLCT) has prepared this report in response

Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients

The efficacy and safety of prolonging prophylaxis for venous thromboembolism in medically ill patients beyond hospital discharge remain uncertain. We hypothesized that extended prophylaxis with apixaban would be safe and more effective than short-term prophylaxis with enoxaparin. METHODS: In this double-blind, double-dummy, placebo-controlled trial, we randomly assigned acutely ill patients who had congestive heart failure or respiratory failure or other medical disorders and at least one additional risk factor for venous thromboembolism and who were hospitalized with an expected stay of at least 3 days to receive apixaban, administered orally at a dose of 2.5 mg twice daily for 30 days, or enoxaparin, administered subcutaneously at a dose of 40 mg once daily for 6 to 14 days. The primary efficacy outcome was the 30-day composite of death related to venous thromboembolism, pulmonary embolism, symptomatic deep-vein thrombosis, or asymptomatic proximal-leg deep-vein thrombosis, as detected with the use of systematic bilateral compression ultrasonography on day 30. The primary safety outcome was bleeding. All efficacy and safety outcomes were independently adjudicated. RESULTS: A total of 6528 subjects underwent randomization, 4495 of whom could be evaluated for the primary efficacy outcome - 2211 in the apixaban group and 2284 in the enoxaparin group. Among the patients who could be evaluated, 2.71% in the apixaban group (60 patients) and 3.06% in the enoxaparin group (70 patients) met the criteria for the primary efficacy outcome (relative risk with apixaban, 0.87; 95% confidence interval [CI], 0.62 to 1.23; P = 0.44). By day 30, major bleeding had occurred in 0.47% of the patients in the apixaban group (15 of 3184 patients) and in 0.19% of the patients in the enoxaparin group (6 of 3217 patients) (relative risk, 2.58; 95% CI, 1.02 to 7.24; P = 0.04). CONCLUSIONS: In medically ill patients, an extended course of thromboprophylaxis with apixaban was not superior to a shorter course with enoxaparin. Apixaban was associated with significantly more major bleeding events than was enoxaparinSupported by Bristol-Myers Squibb and Pfize

New near-IR observations of mesospheric CO2 and H2O clouds on Mars

Carbon dioxide clouds, which are speculated by models on solar and extra-solar planets, have been recently observed near the equator of Mars. The most comprehensive identification of Martian CO2 ice clouds has been obtained by the near-IR imaging spectrometer OMEGA. CRISM, a similar instrument with a higher spatial resolution, cannot detect these clouds with the same method due to its shorter wavelength range. Here we present a new method to detect CO2 clouds using near-IR data based on the comparison of H2O and CO2 ice spectral properties. The spatial and seasonal distributions of 54 CRISM observations containing CO2 clouds are reported, in addition to 17 new OMEGA observations. CRISM CO2 clouds are characterized by grain size in the 0.5-2\mum range and optical depths lower than 0.3. The distributions of CO2 clouds inferred from OMEGA and CRISM are consistent with each other and match at first order the distribution of high altitude (>60km) clouds derived from previous studies. At second order, discrepancies are observed. We report the identification of H2O clouds extending up to 80 km altitude, which could explain part of these discrepancies: both CO2 and H2O clouds can exist at high, mesospheric altitudes. CRISM observations of afternoon CO2 clouds display morphologies resembling terrestrial cirrus, which generalizes a previous result to the whole equatorial clouds season. Finally, we show that morning OMEGA observations have been previously misinterpreted as evidence for cumuliform, and hence potentially convective, CO2 clouds.Comment: Vincendon, M., C. Pilorget, B. Gondet, S. Murchie, and J.-P. Bibring (2011), New near-IR observations of mesospheric CO2 and H2O clouds on Mars, J. Geophys. Res., 116, E00J0

Identification of Antigenic Proteins from Lichtheimia corymbifera for Farmer's Lung Disease Diagnosis.

The use of recombinant antigens has been shown to improve both the sensitivity and the standardization of the serological diagnosis of Farmer's lung disease (FLD). The aim of this study was to complete the panel of recombinant antigens available for FLD serodiagnosis with antigens of Lichtheimia corymbifera, known to be involved in FLD. L. corymbifera proteins were thus separated by 2D electrophoresis and subjected to western blotting with sera from 7 patients with FLD and 9 healthy exposed controls (HEC). FLD-associated immunoreactive proteins were identified by mass spectrometry based on a protein database specifically created for this study and subsequently produced as recombinant antigens. The ability of recombinant antigens to discriminate patients with FLD from controls was assessed by ELISA performed with sera from FLD patients (n = 41) and controls (n = 43) recruited from five university hospital pneumology departments of France and Switzerland. Forty-one FLD-associated immunoreactive proteins from L. corymbifera were identified. Six of them were produced as recombinant antigens. With a sensitivity and specificity of 81.4 and 77.3% respectively, dihydrolipoyl dehydrogenase was the most effective antigen for discriminating FLD patients from HEC. ELISA performed with the putative proteasome subunit alpha type as an antigen was especially specific (88.6%) and could thus be used for FLD confirmation. The production of recombinant antigens from L. corymbifera represents an additional step towards the development of a standardized ELISA kit for FLD diagnosis